Biocardia
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $0 | $3 | $55 | $13 |
Gross Profit | -103 | -51 | -92 | |
EBITDA | -1,632 | -2,169 | -2,064 | |
EBIT | -1,649 | -2,275 | -2,169 | |
Net Income | -1,737 | -1,646 | -2,267 | -2,072 |
Net Change In Cash | 0 | 3 | 55 | 13 |
Free Cash Flow | -2,613 | -1,315 | -1,530 | -1,851 |
Cash | 4,930 | 1,421 | 949 | 1,103 |
Basic Shares | 28 | 1,877 | 1,675 | 1,501 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $477 | $1,352 | $1,015 | $145 |
Gross Profit | -7,249 | -10,549 | 375 | 141 |
EBITDA | -11,560 | -11,819 | -12,570 | -14,435 |
EBIT | -11,644 | -11,901 | -13,210 | -15,001 |
Net Income | -11,571 | -11,913 | -12,621 | -15,005 |
Net Change In Cash | 477 | 1,352 | 1,015 | 145 |
Cost of Revenue | 15,822 | |||
Free Cash Flow | -9,986 | -10,631 | -10,482 | -12,389 |
Cash | 1,103 | 7,363 | 12,872 | 21,407 |
Basic Shares | 1,411 | 1,181 | 1,127 | 674 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.61 |
2024-06-30 | -$0.87 |
2024-03-31 | -$0.09 |
2023-12-31 | -$0.09 |
